In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Medical Device Industry Stays The Course In 2012

Executive Summary

The prospective medical device tax, the continuing decline of venture investing, pricing challenges, austerity measures in Europe, and other headwinds continued to push against the medtech industry in 2012. But emerging clinical and geographic markets, along with an active M&A market, provided the industry with some momentum.


Related Content

Covidien Acquires CV Ingenuity: Highlights Promise In Drug-Coated Balloons
Baxter Acquires Gambro, Becomes Integrated Renal Therapy Leader
Device Companies Follow New Map To Atrial Fibrillation
Could Medtronic’s Kanghui Purchase Set Course For US Entry?
The Fight Against Fat: Start-Ups Look To Serve A Vast Market With Minimally Invasive Bariatric Devices
New Access Devices Create Gateway To Interventional Structural Heart Disease
AdvaMed Steps Up Effort To Link Device Tax Repeal To Job Growth
Cardiac Rhythm Management Market Faces Continued Challenges Ahead
HRS 2011: What's Hot, What's Not, in AF Ablation
COURAGE Suggests Stents Do Not Benefit Stable Coronary Disease Patients


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts